Lamond David 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 9:17 pm Purchase | 2021-03-04 | 13D | Quince Therapeutics, Inc. QNCX | Lamond David | 4,460,154 10.100% | 2,411,216 (+117.68%) | Filing |
| 2021-04-27 11:35 am Purchase | 2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX | Lamond David | 2,048,938 6.900% | 93,773 (+4.80%) | Filing |